The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Critical Illness Commercial Insurance Market Research Report 2024

Global Critical Illness Commercial Insurance Market Research Report 2024

Publishing Date : Feb, 2024

License Type :
 

Report Code : 1902899

No of Pages : 109

Synopsis
Critical illness insurance, otherwise known as critical illness cover or a dread disease policy, is an insurance product in which the insurer is contracted to typically make a lump sum cash payment if the policyholder is diagnosed with one of the specific illnesses on a predetermined list as part of an insurance policy.
The global Critical Illness Commercial Insurance market was valued at US$ 354820 million in 2023 and is anticipated to reach US$ 588660 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
The Critical Illness Commercial Insurance market is a specialized segment within the broader insurance industry that provides coverage for individuals and businesses against the financial impact of severe health crises. This form of insurance offers policyholders a lump-sum payment in the event of a diagnosis of specific critical illnesses, which can include cancer, heart disease, stroke, and other life-altering conditions. It is designed to help policyholders manage the significant medical expenses, treatment costs, and lifestyle adjustments that often accompany a critical illness diagnosis. The market caters to individuals and employers seeking to provide additional financial protection beyond traditional health insurance. Leading insurance companies and providers offer various critical illness insurance policies that can be tailored to individual needs, allowing policyholders to focus on their recovery rather than worrying about the associated financial burden. In an era of rising healthcare costs and increased awareness of critical illnesses, this market plays a crucial role in providing peace of mind and financial security to those facing severe health challenges and underscores the importance of comprehensive coverage in safeguarding against the unexpected.
This report aims to provide a comprehensive presentation of the global market for Critical Illness Commercial Insurance, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Critical Illness Commercial Insurance.
Report Scope
The Critical Illness Commercial Insurance market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Critical Illness Commercial Insurance market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Critical Illness Commercial Insurance companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
China Life Insurance
Ping An Insurance
China Pacific Insurance
Aviva
Legal & General
New China Life Insurance
AXA
Prudential plc
Aegon
Allianz
AIG
UnitedHealthcare
Zurich
MetLife
Dai-ichi Life Group
Sun Life Financial
Huaxia life Insurance
Aflac
Liberty Mutual
HCF
Scottish Windows
Livepool Victoria
Royal London
Vitality
Segment by Type
Disease Insurance
Medical Insurance
Income Protection Insurance
Segment by Application
Cancer
Heart Attack
Stroke
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Critical Illness Commercial Insurance companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Critical Illness Commercial Insurance Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Disease Insurance
1.2.3 Medical Insurance
1.2.4 Income Protection Insurance
1.3 Market by Application
1.3.1 Global Critical Illness Commercial Insurance Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Heart Attack
1.3.4 Stroke
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Critical Illness Commercial Insurance Market Perspective (2019-2030)
2.2 Critical Illness Commercial Insurance Growth Trends by Region
2.2.1 Global Critical Illness Commercial Insurance Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Critical Illness Commercial Insurance Historic Market Size by Region (2019-2024)
2.2.3 Critical Illness Commercial Insurance Forecasted Market Size by Region (2025-2030)
2.3 Critical Illness Commercial Insurance Market Dynamics
2.3.1 Critical Illness Commercial Insurance Industry Trends
2.3.2 Critical Illness Commercial Insurance Market Drivers
2.3.3 Critical Illness Commercial Insurance Market Challenges
2.3.4 Critical Illness Commercial Insurance Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Critical Illness Commercial Insurance Players by Revenue
3.1.1 Global Top Critical Illness Commercial Insurance Players by Revenue (2019-2024)
3.1.2 Global Critical Illness Commercial Insurance Revenue Market Share by Players (2019-2024)
3.2 Global Critical Illness Commercial Insurance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Critical Illness Commercial Insurance Revenue
3.4 Global Critical Illness Commercial Insurance Market Concentration Ratio
3.4.1 Global Critical Illness Commercial Insurance Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Critical Illness Commercial Insurance Revenue in 2023
3.5 Critical Illness Commercial Insurance Key Players Head office and Area Served
3.6 Key Players Critical Illness Commercial Insurance Product Solution and Service
3.7 Date of Enter into Critical Illness Commercial Insurance Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Critical Illness Commercial Insurance Breakdown Data by Type
4.1 Global Critical Illness Commercial Insurance Historic Market Size by Type (2019-2024)
4.2 Global Critical Illness Commercial Insurance Forecasted Market Size by Type (2025-2030)
5 Critical Illness Commercial Insurance Breakdown Data by Application
5.1 Global Critical Illness Commercial Insurance Historic Market Size by Application (2019-2024)
5.2 Global Critical Illness Commercial Insurance Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Critical Illness Commercial Insurance Market Size (2019-2030)
6.2 North America Critical Illness Commercial Insurance Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Critical Illness Commercial Insurance Market Size by Country (2019-2024)
6.4 North America Critical Illness Commercial Insurance Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Critical Illness Commercial Insurance Market Size (2019-2030)
7.2 Europe Critical Illness Commercial Insurance Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Critical Illness Commercial Insurance Market Size by Country (2019-2024)
7.4 Europe Critical Illness Commercial Insurance Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Critical Illness Commercial Insurance Market Size (2019-2030)
8.2 Asia-Pacific Critical Illness Commercial Insurance Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Critical Illness Commercial Insurance Market Size by Region (2019-2024)
8.4 Asia-Pacific Critical Illness Commercial Insurance Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Critical Illness Commercial Insurance Market Size (2019-2030)
9.2 Latin America Critical Illness Commercial Insurance Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Critical Illness Commercial Insurance Market Size by Country (2019-2024)
9.4 Latin America Critical Illness Commercial Insurance Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Critical Illness Commercial Insurance Market Size (2019-2030)
10.2 Middle East & Africa Critical Illness Commercial Insurance Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Critical Illness Commercial Insurance Market Size by Country (2019-2024)
10.4 Middle East & Africa Critical Illness Commercial Insurance Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 China Life Insurance
11.1.1 China Life Insurance Company Detail
11.1.2 China Life Insurance Business Overview
11.1.3 China Life Insurance Critical Illness Commercial Insurance Introduction
11.1.4 China Life Insurance Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.1.5 China Life Insurance Recent Development
11.2 Ping An Insurance
11.2.1 Ping An Insurance Company Detail
11.2.2 Ping An Insurance Business Overview
11.2.3 Ping An Insurance Critical Illness Commercial Insurance Introduction
11.2.4 Ping An Insurance Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.2.5 Ping An Insurance Recent Development
11.3 China Pacific Insurance
11.3.1 China Pacific Insurance Company Detail
11.3.2 China Pacific Insurance Business Overview
11.3.3 China Pacific Insurance Critical Illness Commercial Insurance Introduction
11.3.4 China Pacific Insurance Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.3.5 China Pacific Insurance Recent Development
11.4 Aviva
11.4.1 Aviva Company Detail
11.4.2 Aviva Business Overview
11.4.3 Aviva Critical Illness Commercial Insurance Introduction
11.4.4 Aviva Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.4.5 Aviva Recent Development
11.5 Legal & General
11.5.1 Legal & General Company Detail
11.5.2 Legal & General Business Overview
11.5.3 Legal & General Critical Illness Commercial Insurance Introduction
11.5.4 Legal & General Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.5.5 Legal & General Recent Development
11.6 New China Life Insurance
11.6.1 New China Life Insurance Company Detail
11.6.2 New China Life Insurance Business Overview
11.6.3 New China Life Insurance Critical Illness Commercial Insurance Introduction
11.6.4 New China Life Insurance Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.6.5 New China Life Insurance Recent Development
11.7 AXA
11.7.1 AXA Company Detail
11.7.2 AXA Business Overview
11.7.3 AXA Critical Illness Commercial Insurance Introduction
11.7.4 AXA Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.7.5 AXA Recent Development
11.8 Prudential plc
11.8.1 Prudential plc Company Detail
11.8.2 Prudential plc Business Overview
11.8.3 Prudential plc Critical Illness Commercial Insurance Introduction
11.8.4 Prudential plc Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.8.5 Prudential plc Recent Development
11.9 Aegon
11.9.1 Aegon Company Detail
11.9.2 Aegon Business Overview
11.9.3 Aegon Critical Illness Commercial Insurance Introduction
11.9.4 Aegon Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.9.5 Aegon Recent Development
11.10 Allianz
11.10.1 Allianz Company Detail
11.10.2 Allianz Business Overview
11.10.3 Allianz Critical Illness Commercial Insurance Introduction
11.10.4 Allianz Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.10.5 Allianz Recent Development
11.11 AIG
11.11.1 AIG Company Detail
11.11.2 AIG Business Overview
11.11.3 AIG Critical Illness Commercial Insurance Introduction
11.11.4 AIG Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.11.5 AIG Recent Development
11.12 UnitedHealthcare
11.12.1 UnitedHealthcare Company Detail
11.12.2 UnitedHealthcare Business Overview
11.12.3 UnitedHealthcare Critical Illness Commercial Insurance Introduction
11.12.4 UnitedHealthcare Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.12.5 UnitedHealthcare Recent Development
11.13 Zurich
11.13.1 Zurich Company Detail
11.13.2 Zurich Business Overview
11.13.3 Zurich Critical Illness Commercial Insurance Introduction
11.13.4 Zurich Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.13.5 Zurich Recent Development
11.14 MetLife
11.14.1 MetLife Company Detail
11.14.2 MetLife Business Overview
11.14.3 MetLife Critical Illness Commercial Insurance Introduction
11.14.4 MetLife Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.14.5 MetLife Recent Development
11.15 Dai-ichi Life Group
11.15.1 Dai-ichi Life Group Company Detail
11.15.2 Dai-ichi Life Group Business Overview
11.15.3 Dai-ichi Life Group Critical Illness Commercial Insurance Introduction
11.15.4 Dai-ichi Life Group Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.15.5 Dai-ichi Life Group Recent Development
11.16 Sun Life Financial
11.16.1 Sun Life Financial Company Detail
11.16.2 Sun Life Financial Business Overview
11.16.3 Sun Life Financial Critical Illness Commercial Insurance Introduction
11.16.4 Sun Life Financial Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.16.5 Sun Life Financial Recent Development
11.17 Huaxia life Insurance
11.17.1 Huaxia life Insurance Company Detail
11.17.2 Huaxia life Insurance Business Overview
11.17.3 Huaxia life Insurance Critical Illness Commercial Insurance Introduction
11.17.4 Huaxia life Insurance Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.17.5 Huaxia life Insurance Recent Development
11.18 Aflac
11.18.1 Aflac Company Detail
11.18.2 Aflac Business Overview
11.18.3 Aflac Critical Illness Commercial Insurance Introduction
11.18.4 Aflac Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.18.5 Aflac Recent Development
11.19 Liberty Mutual
11.19.1 Liberty Mutual Company Detail
11.19.2 Liberty Mutual Business Overview
11.19.3 Liberty Mutual Critical Illness Commercial Insurance Introduction
11.19.4 Liberty Mutual Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.19.5 Liberty Mutual Recent Development
11.20 HCF
11.20.1 HCF Company Detail
11.20.2 HCF Business Overview
11.20.3 HCF Critical Illness Commercial Insurance Introduction
11.20.4 HCF Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.20.5 HCF Recent Development
11.21 Scottish Windows
11.21.1 Scottish Windows Company Detail
11.21.2 Scottish Windows Business Overview
11.21.3 Scottish Windows Critical Illness Commercial Insurance Introduction
11.21.4 Scottish Windows Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.21.5 Scottish Windows Recent Development
11.22 Livepool Victoria
11.22.1 Livepool Victoria Company Detail
11.22.2 Livepool Victoria Business Overview
11.22.3 Livepool Victoria Critical Illness Commercial Insurance Introduction
11.22.4 Livepool Victoria Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.22.5 Livepool Victoria Recent Development
11.23 Royal London
11.23.1 Royal London Company Detail
11.23.2 Royal London Business Overview
11.23.3 Royal London Critical Illness Commercial Insurance Introduction
11.23.4 Royal London Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.23.5 Royal London Recent Development
11.24 Vitality
11.24.1 Vitality Company Detail
11.24.2 Vitality Business Overview
11.24.3 Vitality Critical Illness Commercial Insurance Introduction
11.24.4 Vitality Revenue in Critical Illness Commercial Insurance Business (2019-2024)
11.24.5 Vitality Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’